Co-pay Programs in the Crosshairs: An Evidence-based Response to Critics

Co-pay Programs in the Crosshairs: An Evidence-based Response to Critics

Click here to register

Date:
Wednesday, December 4
Time: 11:00 a.m. PT/ 2:00 p.m. ET

We've heard the continuous drumbeat from payers and PBMs: “Co-pay programs interfere with generic substitution!” “They subvert cost-sharing ‘strategies' that payers put in place!” “They increase health care costs!” That's what they say, but what's the real truth? This presentation uses payers' own data to uncover the surprising evidence supporting co-pay offset programs.

Featured Speakers:
Chris Dowd, Senior Vice President of Market and Product Development, PSKW

E.M. (Mick) Kolassa, MBA, PhD – Founding Partner, Medical Marketing Economics

Sponsored by:

You must be a registered member of MMM to post a comment.

Pharma continues to struggle with its image. Exhibit A is the public debate around the price of, and access to, new and innovative meds. As countless transformative technologies hit market, has industry done enough to anchor its permission to innovate? To provide a closer look at trends affecting trust over the past year, MM&M presents this e-book, "The 2015 Edelman Trust Barometer." Click here.

Email Newsletters